Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Orphanet Journal of Rare Diseases

Figure 4

From: Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis

Figure 4

Neutral macro-rheologic impact of cysteamine and rhDNase on DNA. 5 mg/ml calf thymus DNA was exposed to 1 mg/ml or 125 μg/ml of cysteamine and 10 U/ml rhDNase I for 2 h at 37°C and the viscosity of the samples determined by measuring velocity (distance moved (mm) over time (s)) DNase – rhDNAse I; Cys – cysteamine. The experiment was carried out in triplicate and the bars represent the mean.

Back to article page